Gary S. Jacob has been a director at Rasna Therapeutics since 2019. Prior to that, they were chairman of the board at ContraVir Pharmaceuticals from 2014 to 2019. From 2008 to 2018, they were executive chairman of Synergy Pharmaceuticals.
Gary S. Jacob has a Ph.D. in Biochemistry from the University of Wisconsin-Madison and a Bachelor's Degree in Chemistry from the University of Missouri - St. Louis.